Hanger (HNGR) Stock Price, News & Analysis

Company Overview

Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers. The Products & Services segment engages in the distribution of various O&P parts, componentry, and devices to independent O&P providers; development of specialized rehabilitation technologies; and provision of evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2021, the company operated approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. It also distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.

Key Stats

• Today's Range: $18.72 to $18.72
• 50-Day Range: $18.63 to $18.72
• 52-Week Range: $13.42 to $22.67
• Volume: N/A
• Average Volume: 356,429 shs
• Market Capitalization: $732.38 million
• P/E Ratio: 19.71
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HNGR Stock Analysis - Frequently Asked Questions

How were Hanger's earnings last quarter?

Hanger, Inc. (NYSE:HNGR) issued its quarterly earnings results on Monday, November, 8th. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.12. The company earned $289.83 million during the quarter, compared to analysts' expectations of $282.22 million. Hanger had a trailing twelve-month return on equity of 35.72% and a net margin of 3.17%.

What other stocks do shareholders of Hanger own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hanger investors own include Gilead Sciences (GILD), Health Insurance Innovations (HIIQ), M&T Bank (MTB), AbbVie (ABBV), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY) and Incyte (INCY).

Company Calendar

• Last Earnings: 11/08/2021
• Today: 7/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Specialty Outpatient Clinics
• Sub-Industry: N/A
• Current Symbol: NYSE:HNGR
• CIK: 722723
• Web: www.hanger.com
• Phone: (512) 777-3800
• Fax: 301-986-0702
• Employees: 5,200
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.95
• Trailing P/E Ratio: 19.71
• Forward P/E Ratio: 16.42
• P/E Growth: N/A
• Net Income: $41.98 million
• Net Margins: 3.17%
• Pretax Margin: 3.31%
• Return on Equity: 35.72%
• Return on Assets: 4.00%

Debt

• Debt-to-Equity Ratio: 3.71
• Current Ratio: 1.23
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $1.12 billion
• Price / Sales: 0.65
• Cash Flow: $1.88 per share
• Price / Cash Flow: 9.98
• Book Value: $2.85 per share
• Price / Book: 6.57

Miscellaneous

• Outstanding Shares: 39,123,000
• Free Float: 37,417,000
• Market Cap: $732.38 million
• Optionable: Optionable
• Beta: 1.28